CA2474280A1 - Compositions contenant des composants agonistes alpha-2 adrenergiques - Google Patents

Compositions contenant des composants agonistes alpha-2 adrenergiques Download PDF

Info

Publication number
CA2474280A1
CA2474280A1 CA002474280A CA2474280A CA2474280A1 CA 2474280 A1 CA2474280 A1 CA 2474280A1 CA 002474280 A CA002474280 A CA 002474280A CA 2474280 A CA2474280 A CA 2474280A CA 2474280 A1 CA2474280 A1 CA 2474280A1
Authority
CA
Canada
Prior art keywords
alpha
adrenergic agonist
agonist components
compositions containing
containing alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002474280A
Other languages
English (en)
Other versions
CA2474280C (fr
Inventor
Orest Olejnik
Edward D. S. Kerslake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32963036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2474280(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority claimed from CA002402405A external-priority patent/CA2402405C/fr
Publication of CA2474280A1 publication Critical patent/CA2474280A1/fr
Application granted granted Critical
Publication of CA2474280C publication Critical patent/CA2474280C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002474280A 2000-07-14 2001-07-09 Compositions contenant des composants agonistes alpha-2 adrenergiques Expired - Lifetime CA2474280C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21820000P 2000-07-14 2000-07-14
US60/218,200 2000-07-14
CA002402405A CA2402405C (fr) 2000-07-14 2001-07-09 Compositions contenant des composants agonistes alpha-2 adrenergiques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002402405A Division CA2402405C (fr) 2000-07-14 2001-07-09 Compositions contenant des composants agonistes alpha-2 adrenergiques

Publications (2)

Publication Number Publication Date
CA2474280A1 true CA2474280A1 (fr) 2002-01-24
CA2474280C CA2474280C (fr) 2008-06-10

Family

ID=32963036

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002474280A Expired - Lifetime CA2474280C (fr) 2000-07-14 2001-07-09 Compositions contenant des composants agonistes alpha-2 adrenergiques

Country Status (1)

Country Link
CA (1) CA2474280C (fr)

Also Published As

Publication number Publication date
CA2474280C (fr) 2008-06-10

Similar Documents

Publication Publication Date Title
WO2002005853A3 (fr) Compositions contenant des composants agonistes alpha-2 adrenergiques
MX2007002383A (es) Composiciones que contienen componentes agonistas alfa-2-adrenergicos.
AU2001276942A1 (en) Mixed solubility borate preservative
AU2002363105A1 (en) Methods for determining toxicity reversing agents
IL154981A0 (en) Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
MXPA03007088A (es) Composicion lubricante.
MXPA02009773A (es) Derivados de indolin-2-ona y su uso como ligandos de receptores de ocitocina.
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
IL161857A0 (en) Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
ECSP034600A (es) Compuestos de lactama
EP1767193A3 (fr) Compositions pharmaceutiques
IL149030A0 (en) Pharmaceutical compositions containing rifampicin, isoniazid or combinations thereof
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
CA2316112A1 (fr) Agents de demoulage pour matieres bitumineuses
WO2002053519A3 (fr) Analogues de polyamine hydrophobe et procedes d'utilisation correspondants
YU13301A (sh) Muskarinski agonisti i antagonisti
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
TWI256304B (en) Pharmaceutical compositions based on azetidine derivatives
MXPA03009048A (es) Agonistas de la somatostatina.
EG25796A (en) Indanamide derivatives as muscarinic agonists
AU2118801A (en) Thiadizole dimer additives and lubricating compositions containing the same
CA2481593A1 (fr) Composition liquide biologiquement stable contenant le fviii, le fvw ou le complexe fviii/fvw d'origine humaine
ZA200005118B (en) Stable, high available halogen 1,3,5-triazine-2,4,6-trione compositions having rapid dissolution rates.
ATE377068T1 (de) Tensidzusammensetzungen, verbesserungsmittel enthaltend

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210709